| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/08/2011 | CN102089002A Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses |
| 06/08/2011 | CN102089001A Immunity-inducing agent and method for detection of cancer |
| 06/08/2011 | CN102089000A Vaccine for the treatment of alzheimer's disease |
| 06/08/2011 | CN102088994A Indoleamine 2, 3-dioxygenase based immunotherapy |
| 06/08/2011 | CN102088958A Methods and compositions for enhanced delivery of macromolecules |
| 06/08/2011 | CN102086453A Tumor DNA vaccine taking mucin 1 and survivin as targets and viral vector vaccine |
| 06/08/2011 | CN102086447A Duck virus hepatitis strains and inactivated vaccine |
| 06/08/2011 | CN102086446A Strain of Adenoviridae and application thereof |
| 06/08/2011 | CN102085377A Immunogenic composition and methods |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085371A Medical gargle product for Xerostomia and preparation method thereof |
| 06/08/2011 | CN102085370A Oral spray for inflammatory diseases of oral cavity and preparation method thereof |
| 06/08/2011 | CN102085369A Medical gel product for xerostomia and preparation method thereof |
| 06/08/2011 | CN102085368A Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating systemic lupus erythematosus |
| 06/08/2011 | CN102085367A Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating rheumatoid arthritis |
| 06/08/2011 | CN102085366A Compound vaccine adjuvant |
| 06/08/2011 | CN102085365A Application of thymopentin in intranasal vaccine |
| 06/08/2011 | CN102085364A Application of thymopentin in emulsion type injection vaccine |
| 06/08/2011 | CN102085363A Vibrio cholerae O139 capsular polysaccharide conjugate vaccine and preparation method thereof |
| 06/08/2011 | CN102085362A Polypeptide vaccine for treating diseases caused by highly pathogenic avian influenza viruses H5N1 |
| 06/08/2011 | CN102085354A Polypeptide drug for treating tumors caused by human papilloma virus 16 (HPV-16) |
| 06/08/2011 | CN102085353A Polypeptide drug for treating tumors caused by human papilloma virus 18 (HPV-18) |
| 06/08/2011 | CN101632836B DNA vaccine for Edwardsiella tarda and construction and application thereof |
| 06/08/2011 | CN101603035B Porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and method for producing living vaccine with same |
| 06/08/2011 | CN101503694B Rearranged bacterial virus bacteriolysis gene, perforating vector thereof and use in vaccine preparation |
| 06/08/2011 | CN101380470B Pig parvovirus live vaccine |
| 06/08/2011 | CN101352571B Medicament for treating encephalitis b and preparation method thereof |
| 06/08/2011 | CN101130074B Medicament for treating and/or preventing hepatitis B |
| 06/08/2011 | CN101121937B Colibacillus gene engineering bacterin K88-K99-LT for firstborn piglet diarrhea |
| 06/08/2011 | CN101121936B Colibacillus gene engineering bacterin 987P-ST-F41 for firstborn piglet diarrhea |
| 06/07/2011 | US7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate |
| 06/07/2011 | US7956164 Device for enhancing immunostimulatory capabilities of T-cells |
| 06/07/2011 | US7956160 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/07/2011 | US7956034 FSH mutant with increased glycosylation and longer half-life; for inducing folliculogenesis in human; treating an infertile mammal |
| 06/07/2011 | US7955845 Transgenic cells comprising enhanced immune response for use in treatment of infections, cancers and pathologies associated with transplantation |
| 06/07/2011 | US7955833 Derived from soy hydrolysate and yeast hydrolysate; useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal proteins |
| 06/07/2011 | US7955605 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 06/07/2011 | US7955604 Nucleic acids and proteins from streptococcus groups A and B |
| 06/07/2011 | US7955602 Annexin proteins and autoantibodies as serum markers for cancer |
| 06/07/2011 | US7955601 Immunogenic agents against Burkholderia psudomallei and/or Burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from Burkholderia pseudomallei |
| 06/07/2011 | US7955600 Attenuated salmonella SP12 mutants as antigen carriers |
| 06/07/2011 | US7955599 Cytomegaloviral specific immunoglobulin for use in diagnosis and treatment of cardiovascular disorders |
| 06/07/2011 | US7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
| 06/07/2011 | US7955597 Anti-IL-6 antibodies, compositions, methods and uses |
| 06/07/2011 | US7955596 B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 06/07/2011 | US7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2378866C Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2368391C Human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 06/07/2011 | CA2361837C Human papilloma virus vaccine formulations |
| 06/07/2011 | CA2187083C Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/07/2011 | CA2165949C Tuberculosis vaccine |
| 06/03/2011 | WO2011066501A1 Antibody fc mutants with ablated effector functions |
| 06/03/2011 | WO2011066454A1 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 06/03/2011 | WO2011066417A2 Antibodies and conjugates for modulators of angiogenesis |
| 06/03/2011 | WO2011066390A2 Nanoscale adjuvants and related pharmaceutical compositions and methods |
| 06/03/2011 | WO2011066378A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/03/2011 | WO2011066374A2 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 06/03/2011 | WO2011066371A2 Antibodies to il-6 and use thereof |
| 06/03/2011 | WO2011066369A2 Antagonists of il-6 to raise albumin and/or lower crp |
| 06/03/2011 | WO2011066342A2 Simultaneous inhibition of pd-l1/pd-l2 |
| 06/03/2011 | WO2011066284A1 Methods and compositions for the treatment of immune disorders |
| 06/03/2011 | WO2011065923A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011064664A2 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064399A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
| 06/03/2011 | WO2011064398A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
| 06/03/2011 | WO2011064382A1 Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| 06/03/2011 | WO2011064254A1 Use of a vaccine against the vzv/hsv3 virus for treating hsv1 and/or hsv2 herpes virus infections |
| 06/03/2011 | WO2011063523A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/03/2011 | WO2011044563A3 Il-17 family cytokine compositions and uses |
| 06/03/2011 | WO2011044492A8 Methods of treatment and screening assays for hif-1alpha regulation |
| 06/03/2011 | WO2011043962A3 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| 06/03/2011 | WO2011011453A3 Phenotyping tumor-infiltrating leukocytes |
| 06/03/2011 | WO2011011384A3 Synthesis of dendrimer conjugates |
| 06/03/2011 | WO2011009854A3 Vaccine for the prevention of acute lymphoblastic leukemia |
| 06/03/2011 | WO2010138193A3 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 06/03/2011 | WO2010138192A3 Nanocarriers possessing components with different rates of release |
| 06/03/2011 | WO2010025109A8 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) |
| 06/03/2011 | CA2782218A1 Antibody fc mutants with ablated effector functions |
| 06/03/2011 | CA2782007A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
| 06/03/2011 | CA2782004A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
| 06/03/2011 | CA2781645A1 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 06/03/2011 | CA2778714A1 Targeted binding agents against b7-h1 |
| 06/03/2011 | CA2776513A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110131669 Ganglioside epitopes for treating guillain-barre syndrome |
| 06/02/2011 | US20110130705 Therapy for vitiligo |
| 06/02/2011 | US20110130328 Flavivirus fusion inhibitors |
| 06/02/2011 | US20110129525 Mucosal membrane receptor and uses thereof |
| 06/02/2011 | US20110129524 Therapeutic agent for cancer, and method for treatment of cancer |
| 06/02/2011 | US20110129518 Probiotic products for pet applications |
| 06/02/2011 | US20110129503 Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129501 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 06/02/2011 | US20110129500 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |